Thalassaemia drug, Desferal

Thalassaemia drug, Desferal

M625/1582 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 36.4MB

Downloadable file size: 1.7MB

Price image Pricing

Please login to use the price calculator


Caption: Thalassaemia drug. Bottle of the chelating agent Desferal (deferoxamine). A chelating agent removes heavy metals. In this case it removes excess iron from the blood. This is a common condition in patients who have to undergo regular blood transfusions, for example patients with thalassaemia. Thalassaemia is an inherited condition where the red blood cells are fragile and easily damaged. For chronic conditions like thalassaemia, the drug is infused gradually over several hours daily, by subcutaneous injection. Desferal can also be used to treat iron and aluminium poisoning. The use of Desferal is preferred to other chelating agents, due to fewer side-effects.

Release details: Model release not required. Property release not required.

Keywords: 21st century, biochemical, biochemistry, blood, bottle, chelating agent, deferoxamine, desferal, drug, europe, european, excess, haematology, healthcare, heavy metal, hematology, inorganic chemistry, iron, italian, italy, medical, medicine, pharmaceutic, pharmaceutical, pharmaceutics, pharmacological, pharmacology, phial, poisoning, removing, still life, still-life, thalassaemia, thalassemia, toxicity, transfusions, treatment, vial

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.